Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in Oncology, today announced the appointment of Elena Garralda, MD, Ph.D., to ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix ...

AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

Cancer therapies do not always succeed in eliminating tumour cells. Some of these cells enter a state of senescence—a latent, ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

Researchers have identified various distinctive immune cells in cow's milk, creating potential avenues for enhancing animal ...

Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on February 3, 2025, the Compensation Committee of the company’s Board of Directors granted to 18 new employees inducement awards ...

The Duchess of Cambridge , 43, has long been an advocate for forest bathing, well-before her shock cancer diagnosis was ...

The Duchess of Cambridge, 43, has long been an advocate for forest bathing, well-before her shock cancer diagnosis was ...